Ensysce Biosciences Inc (ENSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 493 | 1,371 | 1,320 | 1,304 | 3,419 |
| Gross Profit | 493 | 1,371 | 1,320 | 1,304 | 3,419 |
| Operating Expenses | 4,234 | 3,122 | 3,287 | 4,880 | 2,774 |
| Operating Income | -3,741 | -1,751 | -1,968 | -3,577 | 645 |
| Interest Expense | 6 | 3 | 4 | 11 | 4 |
| Other Income | 18 | 20 | 26 | 23 | 21 |
| Pre-tax Income | -3,729 | -1,734 | -1,946 | -3,564 | 662 |
| Net Income Continuous | -3,729 | -1,734 | -1,946 | -3,564 | 662 |
| Net Income | $-3,729 | $-1,734 | $-1,946 | $-3,564 | $662 |
| EPS Basic Total Ops | -1.29 | -0.79 | -1.39 | -0.89 | 1.00 |
| EPS Basic Continuous Ops | -1.29 | -0.79 | -1.39 | -0.90 | 1.00 |
| EPS Diluted Total Ops | -1.29 | -0.79 | -1.39 | -0.89 | 1.00 |
| EPS Diluted Continuous Ops | -1.29 | -0.79 | -1.39 | -0.90 | 1.00 |
| EPS Diluted Before Non-Recurring Items | -1.29 | -0.79 | -1.39 | -2.90 | 1.05 |
| EBITDA(a) | $-3,741 | $-1,751 | $-1,968 | $-3,577 | $645 |